These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 36963247)

  • 1. Untargeted plasma
    Fonseca RID; Menezes LRA; Santana-Filho AP; Schiefer EM; Pecoits-Filho R; Stinghen AEM; Sassaki GL
    J Pharm Biomed Anal; 2023 May; 229():115339. PubMed ID: 36963247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of Trimethylamine-N-Oxide in Chronic Kidney Disease: Contribution of Decreased Glomerular Filtration Rate.
    Pelletier CC; Croyal M; Ene L; Aguesse A; Billon-Crossouard S; Krempf M; Lemoine S; Guebre-Egziabher F; Juillard L; Soulage CO
    Toxins (Basel); 2019 Nov; 11(11):. PubMed ID: 31683880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.
    Lucio-Gutiérrez JR; Cordero-Pérez P; Ávila-Velázquez JL; Torres-González L; Farías-Navarro IC; Govea-Torres G; Sánchez-Martínez C; García-Hernández PA; Coello-Bonilla J; Pérez-Trujillo M; Parella T; Waksman-Minsky NH; Saucedo AL
    J Pharm Biomed Anal; 2024 Sep; 247():116240. PubMed ID: 38820837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot metabolic profiling study in serum of patients with chronic kidney disease based on (1) H-NMR-spectroscopy.
    Qi S; Ouyang X; Wang L; Peng W; Wen J; Dai Y
    Clin Transl Sci; 2012 Oct; 5(5):379-85. PubMed ID: 23067349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of nuclear magnetic resonance spectroscopy for the detection of metabolic disorders in patients with moderate kidney insufficiency.
    Mika A; Wojtowicz W; Ząbek A; Młynarz P; Chmielewski M; Sledzinski T; Stepnowski P
    J Pharm Biomed Anal; 2018 Feb; 149():1-8. PubMed ID: 29100025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal function is associated with plasma trimethylamine-N-oxide, choline, L-carnitine and betaine: a pilot study.
    Guo F; Dai Q; Zeng X; Liu Y; Tan Z; Zhang H; Ouyang D
    Int Urol Nephrol; 2021 Mar; 53(3):539-551. PubMed ID: 32945995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014).
    Chu NM; Hong J; Harasemiw O; Chen X; Fowler KJ; Dasgupta I; Bohm C; Segev DL; McAdams-DeMarco MA;
    Nephrol Dial Transplant; 2022 Oct; 37(11):2180-2189. PubMed ID: 34850174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rule-Mining for the Early Prediction of Chronic Kidney Disease Based on Metabolomics and Multi-Source Data.
    Luck M; Bertho G; Bateson M; Karras A; Yartseva A; Thervet E; Damon C; Pallet N
    PLoS One; 2016; 11(11):e0166905. PubMed ID: 27861591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatinine- vs. cystatin C-based equations compared with 99mTcDTPA scintigraphy to assess glomerular filtration rate in chronic kidney disease.
    Trimarchi H; Muryan A; Martino D; Toscano A; Iriarte R; Campolo-Girard V; Forrester M; Pomeranz V; Fitzsimons C; Lombi F; Young P; Raña MS; Alonso M
    J Nephrol; 2012; 25(6):1003-15. PubMed ID: 22322818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H; Li G; Tomlin A; Tilyard MW; Walker R; Schollum J
    Nephrology (Carlton); 2019 Mar; 24(3):308-315. PubMed ID: 29717528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease.
    Missailidis C; Hällqvist J; Qureshi AR; Barany P; Heimbürger O; Lindholm B; Stenvinkel P; Bergman P
    PLoS One; 2016; 11(1):e0141738. PubMed ID: 26751065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Magnetic Resonance-Based Metabolomics Approach Revealed the Intervention Effect of Using Complementary and Alternative Medicine (CAM) by CKD Patients.
    Gupta N; Yadav DK; Gautam S; Kumar A; Kumar D; Prasad N
    ACS Omega; 2023 Feb; 8(8):7722-7737. PubMed ID: 36872986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gap acidosis except lactic acidosis develops and progresses during chronic kidney disease stage G5.
    Tanemoto M
    Clin Exp Nephrol; 2019 Aug; 23(8):1045-1049. PubMed ID: 31062197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease.
    Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL
    Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and urinary amino acid metabolomic profiling in patients with different levels of kidney function.
    Duranton F; Lundin U; Gayrard N; Mischak H; Aparicio M; Mourad G; Daurès JP; Weinberger KM; Argilés A
    Clin J Am Soc Nephrol; 2014 Jan; 9(1):37-45. PubMed ID: 24235289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and awareness of chronic kidney disease among adult diabetic outpatients in Northeast Ethiopia.
    Fiseha T; Tamir Z
    BMC Nephrol; 2020 Apr; 21(1):129. PubMed ID: 32293323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Li H; Ren M; Li Q
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzymatic creatinine assays allow estimation of glomerular filtration rate in stages 1 and 2 chronic kidney disease using CKD-EPI equation.
    Kuster N; Cristol JP; Cavalier E; Bargnoux AS; Halimi JM; Froissart M; Piéroni L; Delanaye P;
    Clin Chim Acta; 2014 Jan; 428():89-95. PubMed ID: 24220551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease.
    Abe M; Maruyama N; Oikawa O; Maruyama T; Okada K; Soma M
    Scand J Clin Lab Invest; 2015 Sep; 75(5):421-7. PubMed ID: 26067610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.